BR9608909A - Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto - Google Patents
Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do compostoInfo
- Publication number
- BR9608909A BR9608909A BR9608909A BR9608909A BR9608909A BR 9608909 A BR9608909 A BR 9608909A BR 9608909 A BR9608909 A BR 9608909A BR 9608909 A BR9608909 A BR 9608909A BR 9608909 A BR9608909 A BR 9608909A
- Authority
- BR
- Brazil
- Prior art keywords
- animals
- compound
- increase
- growth
- patuitaria
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 2
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
- 239000008267 milk Substances 0.000 title 1
- 210000004080 milk Anatomy 0.000 title 1
- 235000013336 milk Nutrition 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 210000002268 wool Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK71995 | 1995-06-22 | ||
DK137195 | 1995-12-04 | ||
PCT/DK1996/000266 WO1997000894A1 (en) | 1995-06-22 | 1996-06-19 | Compounds with growth hormone releasing properties |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9608909A true BR9608909A (pt) | 1999-03-02 |
Family
ID=26064522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9608909A BR9608909A (pt) | 1995-06-22 | 1996-06-19 | Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0833845A1 (hu) |
KR (1) | KR19990028303A (hu) |
AU (1) | AU711104B2 (hu) |
BR (1) | BR9608909A (hu) |
CA (1) | CA2224434A1 (hu) |
CZ (1) | CZ287948B6 (hu) |
HU (1) | HUP9802821A3 (hu) |
IL (1) | IL122371A0 (hu) |
NO (1) | NO975992L (hu) |
PL (1) | PL186520B1 (hu) |
TW (1) | TW458958B (hu) |
WO (1) | WO1997000894A1 (hu) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998008492A1 (en) * | 1996-08-29 | 1998-03-05 | Novo Nordisk A/S | Transdermal delivery of peptides |
EP1005484A1 (en) | 1997-06-20 | 2000-06-07 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
US6127341A (en) * | 1997-06-20 | 2000-10-03 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
CN1213036C (zh) | 1997-08-22 | 2005-08-03 | 科研制药株式会社 | 新的酰胺类衍生物 |
AU766305B2 (en) | 1998-01-16 | 2003-10-16 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
EA003860B1 (ru) * | 1998-05-12 | 2003-10-30 | Варнер-Ламберт Компани | КОМБИНАЦИИ ИНГИБИТОРОВ ПРОТЕИН ФАРНЕЗИЛТРАНСФЕРАЗЫ И HMG KoA РЕДУКТАЗЫ И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАКА |
KR100907638B1 (ko) * | 1998-06-30 | 2009-07-14 | 노보 노르디스크 에이/에스 | 성장 호르몬 방출성을 가지는 화합물 |
US6919315B1 (en) | 1998-06-30 | 2005-07-19 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
US6468974B1 (en) | 1998-08-14 | 2002-10-22 | The Administrators Of The Tulane Educational Fund | Compounds having growth hormone releasing activity |
AU759022B2 (en) | 1999-02-18 | 2003-04-03 | Kaken Pharmaceutical Co., Ltd. | Novel amide derivatives as growth hormone secretagogues |
ATE446758T1 (de) | 2000-05-31 | 2009-11-15 | Pfizer Prod Inc | Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts |
EP1343751A2 (en) | 2000-12-20 | 2003-09-17 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
JP2005506949A (ja) | 2000-12-20 | 2005-03-10 | ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー | ケモカイン受容体の調節剤としてのジアミン |
TWI331922B (en) | 2002-08-09 | 2010-10-21 | Ipsen Pharma Sas | Growth hormone releasing peptides |
US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
US8138191B2 (en) | 2007-01-11 | 2012-03-20 | Critical Outcome Technologies Inc. | Inhibitor compounds and cancer treatment methods |
ES2604943T3 (es) | 2007-02-09 | 2017-03-10 | Ocera Therapeutics, Inc. | Moduladores macrocíclicos del receptor de la grelina y procedimientos de uso de los mismos |
US8466151B2 (en) | 2007-12-26 | 2013-06-18 | Critical Outcome Technologies, Inc. | Compounds and method for treatment of cancer |
CA2999435A1 (en) | 2010-04-01 | 2011-10-06 | Critical Outcome Technologies Inc. | Compounds and method for treatment of hiv |
WO2013190520A2 (en) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
US20170121385A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5663146A (en) * | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
HU224345B1 (hu) * | 1993-12-23 | 2005-08-29 | Novo Nordisk A/S. | Növekedési hormont felszabadító tulajdonságú peptidek, ezeket hatóanyagként tartalmazó gyógyszerkészítmények és alkalmazásuk |
US5798337A (en) * | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
-
1996
- 1996-06-19 BR BR9608909A patent/BR9608909A/pt not_active Application Discontinuation
- 1996-06-19 AU AU61882/96A patent/AU711104B2/en not_active Ceased
- 1996-06-19 WO PCT/DK1996/000266 patent/WO1997000894A1/en not_active Application Discontinuation
- 1996-06-19 CZ CZ19974081A patent/CZ287948B6/cs not_active IP Right Cessation
- 1996-06-19 CA CA002224434A patent/CA2224434A1/en not_active Abandoned
- 1996-06-19 HU HU9802821A patent/HUP9802821A3/hu unknown
- 1996-06-19 EP EP96920742A patent/EP0833845A1/en not_active Withdrawn
- 1996-06-19 KR KR1019970709617A patent/KR19990028303A/ko not_active Application Discontinuation
- 1996-06-19 IL IL12237196A patent/IL122371A0/xx not_active IP Right Cessation
- 1996-06-19 PL PL96324200A patent/PL186520B1/pl unknown
- 1996-06-28 TW TW085107813A patent/TW458958B/zh not_active IP Right Cessation
-
1997
- 1997-12-19 NO NO975992A patent/NO975992L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0833845A1 (en) | 1998-04-08 |
MX9710377A (es) | 1998-03-29 |
CZ287948B6 (cs) | 2001-03-14 |
IL122371A0 (en) | 1998-06-15 |
WO1997000894A1 (en) | 1997-01-09 |
CZ408197A3 (cs) | 1998-05-13 |
KR19990028303A (ko) | 1999-04-15 |
PL324200A1 (en) | 1998-05-11 |
JPH11507928A (ja) | 1999-07-13 |
CA2224434A1 (en) | 1997-01-09 |
TW458958B (en) | 2001-10-11 |
NO975992D0 (no) | 1997-12-19 |
NO975992L (no) | 1998-02-20 |
HUP9802821A2 (hu) | 1999-03-29 |
PL186520B1 (pl) | 2004-01-30 |
HUP9802821A3 (en) | 2000-03-28 |
AU6188296A (en) | 1997-01-22 |
JP4173541B2 (ja) | 2008-10-29 |
AU711104B2 (en) | 1999-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9608909A (pt) | Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto | |
BR9608956A (pt) | Composto composição farmacéutica e processos para aliviar a dor e para preparar um composto | |
PT912194E (pt) | Formula de vacina polinucleotidica particularmente contra doenca respiratoria dos bovinos | |
ATE178204T1 (de) | Intravaginale vorrichtung zur verabreichung von 17beta-oestradiol vorläufer | |
BR9608908A (pt) | Composto composição farmacêutica processos para aliviar dor e para preparar um composto | |
DE3876756T2 (de) | Vorrichtung zur gesteuerten freigabe und verabreichung von wirkstoffen an tierisches gewebe. | |
BR9609670A (pt) | Compostos processos para a preparação dos mesmos uso dos mesmos e processos de controlar pestes fúngicidas e pestes animais | |
DE68916430D1 (de) | Arzneimittelzubereitung zur behandlung von mastitis bei tier und mensch. | |
BR9605907A (pt) | Formulaçao de liberaçao prolongada de um hormônio de crescimento animal e processo para sua preparaçao | |
ITMI951538A0 (it) | Procedimento ed impianto per la disidratazione di foraggio particolarmente per la disidratazione dell'erba medica | |
PT801561E (pt) | Composicao e metodos para a entrega transdermica de drogas labeis a acido | |
FR2748394B1 (fr) | Applicateur de medicaments pour animaux | |
BR9603012A (pt) | Composição de resina produto moldado coleira brinco e medalha para animais processo para controlar a exsudação do composto ativo e uso do produto moldado | |
BR9506235A (pt) | Compostos enanciométricos únicos uso dos mesmos processos para sua preparação e de(+)-e-(-)-5-carbometoxi-6-metail-2-((3,4-dimetoxi-2-piridinil)metil )1-h-benzimidazol ou seu sal de sódio em suas for mas cristalinas para inibição de secreção de ácido gástrico e para o tratamento de doenças inflamatórias gastrointestinais e preparação farmacêutica | |
FI972949A (fi) | Lääkemuoto kollagenaasin vapauttamiseksi haavoihin ja sen valmistusmenetelmiä | |
BR9709930A (pt) | Composto composição farmacêutica uso de um composto e processos para tratamento de um indivíduo humano ou animal e para preparação de um composto | |
ATE316379T1 (de) | Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen | |
BR9612362A (pt) | Compostos produto adequado para o controle de pragas animais ou de oragas fúgidas processos para o controle de pragas fúngidas e animais e para a preparação dos compostos utilização dos compostos e produtos intermediários | |
AU1581795A (en) | Lure for facilitating the administration of drugs to certain animals, particularly dogs | |
BR9200318A (pt) | Derivados de 3-aril-pirrolidin-2,4-diona biciclicos-substituidos,processo para a sua preparacao,composicoes praguicidas,processo para o combate de pragas animais,aplicacao dos ditos derivados,processo para a preparacao de praguicidas,processo para o combate de ervas daninhas e processo para a preparacao de composicoes herbicidas | |
ATE292458T1 (de) | Transdermales therapeutisches system zur verabreichung von (s)-3-methyl-5-(1-methyl-2- pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen salze | |
FR2739778B1 (fr) | Formulation topique destinee a traiter la maladie de la douve du foie chez l'animal | |
BR9501691A (pt) | Derivado de ácido graxo processo para a preparação de um derivado de ácido graxo composição farmacêutica e método para a prevenção e ou tratamento de doenças humanas ou animais | |
FR2683147B1 (fr) | Systeme vehicule de principe actif permettant l'administration voie orale chez les poissons et crustaces. | |
BR8804221A (pt) | Processo para a preparacao de um composto,composicoes praguicidas,aplicacao,processo para combater pragas em animais e plantas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |